跳至主要内容
临床试验/ACTRN12609000524291
ACTRN12609000524291尚未招募4 期

Do subjects with symptomatic knee osteoarthritis demonstrate more widespread mechanical and cold hyperalgesia compared with matched controls, and can this hyperalgesia be better modified by a 2-week course of Arcoxia than placebo?

Curtin University of technology0 个研究点目标入组 80 人开始时间: 2009年7月1日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
50 Years 至 o limit(—)
性别
All

入选标准

  • i) unilateral diagnosis of Knee Osteoarthritis (OA) >6 months
  • ii) knee pain >4/10 on WOMAC pain subscale
  • iii) if pain in contralateral knee, no greater than mild
  • iv) no other significant joint involvement
  • v) American Rheumatology Association (ARA) functional Class I, II or III
  • vi) no athroscopy or injections into index knee in last 6 months.

排除标准

  • i) history of systemic inflammatory or chronic pain disorders (especially fibromyalgia)
  • ii) neurological deficit
  • iii) recent (<6 months) lower limb surgery
  • iv) allergic reaction to Non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin
  • v) skin allergies, dermatitis
  • vi) contraindications to Cox-2 inhibitors: congestive heart failure (New York Heart Association Classifications II-IV); unstable hypertension; ischaemic heart disease, peripheral artery disease, cerebrovascular disease including coronary artery bypass graft or angioplasty within 1 year; severe hepatic dysfunction; active gastro-intestinal tract bleeding or peptic ulceration; reduced creatinine clearance <30mL/min
  • vii) current use of high dose (>325mg daily) aspirin

研究者

发起方
Curtin University of technology

相似试验